(Q35039520)

5 August 2017

title

Severe viral respiratory infections: are bugs bugging? (English)

1 reference

5 August 2017

M Vissers

1

1 reference

5 August 2017

R de Groot

series ordinal

2

1 reference

5 August 2017

G Ferwerda

series ordinal

3

1 reference

5 August 2017

publication date

13 November 2013

1 reference

5 August 2017

1 reference

5 August 2017

volume

7

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

227-238

1 reference

Human vaccine research and development: an overview

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Lung infection--a public health priority

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

The burden of respiratory syncytial virus infection in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Infection with multiple viruses is not associated with increased disease severity in children with bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

How host-microbial interactions shape the nutrient environment of the mammalian intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Host-bacterial mutualism in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Ecological and evolutionary forces shaping microbial diversity in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

The microbiome in infectious disease and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

The impact of the gut microbiota on human health: an integrative view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

21 January 2018

The price of immunity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Interactions between the microbiota and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

The effects of commensal microbiota on immune cell subsets and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Reciprocal interactions of the intestinal microbiota and immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Does the microbiota regulate immune responses outside the gut?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Antibiotic use during infancy promotes a shift in the T(H)1/T(H)2 balance toward T(H)2-dominant immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Nasopharyngeal microbiota in infants with acute otitis media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

The human nasal microbiota and Staphylococcus aureus carriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Bacteria in the nose of young adults during wellness and rhinovirus colds: detection by culture and microarray methods in 100 nasal lavage specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Characterization of the upper respiratory tract microbiomes of patients with pandemic H1N1 influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Topographical continuity of bacterial populations in the healthy human respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Disordered microbial communities in asthmatic airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Analysis of the lung microbiome in the "healthy" smoker and in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Comparison of the respiratory microbiome in healthy nonsmokers and smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

The microbiome of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Commensal bacteria calibrate the activation threshold of innate antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Probiotics for the prevention of respiratory tract infections: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Role of the indigenous microbiota in maintaining the virus-specific CD8 memory T cells in the lung of mice infected with murine cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Staphylococcal enterotoxins A and B enhance rhinovirus replication in A549 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Streptococcus pneumoniae exposure is associated with human metapneumovirus seroconversion and increased susceptibility to in vitro HMPV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Respiratory syncytial virus infection augments NOD2 signaling in an IFN-β-dependent manner in human primary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

A role for Streptococcus pneumoniae in virus-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

NASOPHARYNGEAL FLORA IN HEALTH AND DURING RESPIRATORY DISEASE IN ISOLATED COMMUNITIES IN ALABAMA AND LABRADOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

THE ASSOCIATION OF PNEUMOCOCCI, HEMOPHILUS INFLUENZAE, AND STREPTOCOCCUS HEMOLYTICUS WITH CORYZA, PHARYNGITIS, AND SINUSITIS IN MAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Microbiota regulates the TLR7 signaling pathway against respiratory tract influenza A virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

A metagenomic study of diet-dependent interaction between gut microbiota and host in infants reveals differences in immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Continued impact of pneumococcal conjugate vaccine on carriage in young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Otitis media, bacterial colonization, and the smoking parent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Spread of Streptococcus pneumoniae and antibiotic-resistant S. pneumoniae from day-care center attendees to their younger siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Development of the human infant intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Beyond bacteria: a study of the enteric microbial consortium in extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Patterns of early gut colonization shape future immune responses of the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Early life: gut microbiota and immune development in infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Microbial exposure during early life has persistent effects on natural killer T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Hay fever, hygiene, and household size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Probiotic strategies for treatment of respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Bifidobacteriumanimalis subsp. lactis BB-12 in reducing the risk of infections in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Effects of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on common respiratory and gastrointestinal infections in shift workers in a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Intragastric and Intranasal Administration of Lactobacillus paracasei NCC2461 Modulates Allergic Airway Inflammation in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

The keystone-pathogen hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Diversity and sharing of Haemophilus influenzae strains colonizing healthy children attending day-care centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Reduced Enterobacterial and Increased Staphylococcal Colonization of the Infantile Bowel: An Effect of Hygienic Lifestyle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.93

Microbiota abnormalities in inflammatory airway diseases - Potential for therapy

21 January 2018

1 reference

12 December 2020

The intestinal microflora in allergic Estonian and Swedish 2-year-old children

1 reference

12 December 2020

Human gut microbiome viewed across age and geography

1 reference

12 December 2020

Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing

1 reference

12 December 2020

Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection

1 reference

12 December 2020

Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota

1 reference

12 December 2020

Microbial communities in the respiratory tract of patients with interstitial lung disease.

1 reference

12 December 2020

Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages

1 reference

12 December 2020

Induction of colonic regulatory T cells by indigenous Clostridium species

1 reference

12 December 2020

Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees

1 reference

12 December 2020

Immune response to Mycoplasma pulmonis in nasal mucosa is modulated by the normal microbiota

1 reference

12 December 2020

Comparative analyses of the bacterial microbiota of the human nostril and oropharynx.

1 reference

12 December 2020

Intestinal microbiota promote enteric virus replication and systemic pathogenesis

1 reference

12 December 2020

H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression

1 reference

12 December 2020

Specific probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Microbiota regulates immune defense against respiratory tract influenza A virus infection

1 reference

12 December 2020

Dysregulation of allergic airway inflammation in the absence of microbial colonization

1 reference

12 December 2020

Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns--Chicago and Los Angeles County, 2004

1 reference

12 December 2020

Bacterial lipopolysaccharide inhibits influenza virus infection of human macrophages and the consequent induction of CD8+ T cell immunity.

1 reference

12 December 2020

Successful transmission of a retrovirus depends on the commensal microbiota

1 reference

12 December 2020

Muramyl peptides and polyinosinic-polycytodylic acid given to mice prior to influenza virus challenge reduces pulmonary disease and mortality

1 reference

12 December 2020

Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects

1 reference

12 December 2020

Identifiers

DOI

10.1038/MI.2013.93

1 reference

5 August 2017

1 reference